Data from a small study at the University of California at San Francisco suggest that magnetic resonance (MR) spectroscopic imaging is better than T2-weighted MR imaging alone for the detection of locally recurrent prostate cancer after definitive external beam radiation therapy (EBRT) as first-line therapy.
Filed under: Management, Treatment | Tagged: detection, magentic resonance imaging, MRI, recurrence | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site
